Skip to main content
. 2020 Jun 11;7:295. doi: 10.3389/fmed.2020.00295

Table 2.

Comorbidities in patients from selected studies.

Study (References) N (% with pneumonia) Diabetes Hypertension Cardiovascular disease Malignancy Chronic liver disease COPD Chronic kidney disease Others (n, %) Any co-morbidity
CROSS-SECTIONAL STUDIES AND CASE SERIES
Chan et al. (30) 6 (100%) 1 (22%) 2 (33%) 1 (22%) Chronic sinusitis (22%)
Chang et al. (31) 13 (62%)
Chen et al. (27) 99 (100%) 40 (40%) 1 (1%) Digestive system disorder (11%), Endocrine system disorder (13%), Nervous system disease (1%) 50 (51%)
Chung et al. (32) 21 (85%)
Huang et al. (25) 41 (100%) 8 (20%) 6 (15%) 6 (15%) 1 (2%) 1 (2%) 1 (2%) 13 (32%)
Kui et al. (26) 137 (100%) 14 (10.2%) 13 (9.5%) 10 (7.3%) 2 (1.5%) 2 (1.5%)
Song et al. (33) 51 (100%) 3 (6%) 5 (10%) 1 (2%) 1 (2%) 1 (2%)
Wang et al. (28) 138 (100%) 14 (10.1%) 43 (31.2%) 20 (14.5%) 10 (7.2%) 4 (2.9%) 4 (2.9%) 4 (2.9%) HIV (1.4%) 64 (46.4%)
Wang et al. (34) 17 (Unspecified) 5 (29%) 7 (41%) 2 (11.7%) 1 (6%) 1 (5.8%) 2 (11.7%) Surgery (29.4%) 11 (64.7%)
杨涛/Yang et al. (35) 10 (100%) 0 0 0 0 0 0 1 (10%)
马慧静/Ma et al. (29)* 22 (86%)
Pooled prevalence (95% CI) 10% (6–15%) 17% (7–28%) 12% (3–23%) 2% (<1–5%) 2% (<1–4%) 1% (<1–3%) 6% (2–15%) 45% (34–56%)
CASE REPORTS (WORLDWIDE)**
Bastola et al. (Nepal) (24) 1 (Pneumonia) No
Holshue et al. (USA) (22) 1 (Pneumonia) No
Kim et al. (S. Korea) (23) 1 (Pneumonia) Yes Yes
Phan et al. (Vietnam) (20) 1 (Pneumonia) Yes Yes Yes Yes Yes
Rothe et al. (Germany) (21) 1 (Mild infection) No
*

Study 马慧静/Ma et al. not included in pooled figures as subjects are children.

**

Case reports from patients in China found in Supplementary Material.

COPD, Chronic Obstructive Pulmonary Disease.